Tumor microenvironment regulates epithelial-mesenchymal transitions in metastasis

Expert Review of Anticancer Therapy

Volumn 12, Issue 7, 2012, Pages 857-859

  Gao, Dingcheng ^a   Mittal, Vivek ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

EMT; MET; metastasis; microenvironment; TGF; versican

Indexed keywords

CD11B ANTIGEN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

CANCER GRADING; CELL TRANSFORMATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MESENCHYMAL EPITHELIAL TRANSITION; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84864618495     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.12.69     Document Type: Review

References (24)

1. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119(6), 1420-1428 (2009).
2. Scheel C, Weinberg RA. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int. J. Cancer 129(10), 2310-2314 (2011).
3. Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704-715 (2008).
4. Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H, Moustakas A. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 27(9), 1218-1230 (2008).
5. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to- mesenchymal transition and stem cell characteristics. Cancer Res. 69(10), 4116-4124 (2009).
6. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 11(11), 1287-1296 (2009).
7. Xue C, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial- mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 63(12), 3386-3394 (2003).
8. Trimboli AJ, Fukino K, De Bruin A et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 68(3), 937-945 (2008).
9. Rhim AD, Mirek ET, Aiello NM et al. EMT and dissemination precede pancreatic tumor formation. Cell 148(1-2), 349-361 (2012).
10. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 65(14), 5996-6000; discussion 6000-6001 (2005).
11. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition? Cancer Res. 65(14), 5991-5995; discussion 5995 (2005).
12. Yates C. Prostate tumor cell plasticity: A consequence of the microenvironment. Adv. Exp. Med. Biol. 720, 81-90 (2011).
13. Gao D, Joshi N, Choi H et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 72(6), 1384-1394 (2012).
14. Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10(5), 593-601 (2008).
15. Korpal M, Ell BJ, Buffa FM et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 17(9), 1101-1108 (2011).
16. Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature 472(7341), 90-94 (2011).
17. Liu W, Laitinen S, Khan S et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med. 15(5), 559-565 (2009).
18. Turajlic S, Furney SJ, Lambros MB et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 22(2), 196-207 (2012).
19. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9(4), 239-252 (2009).
20. Toh B, Wang X, Keeble J et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 9(9), e1001162 (2011).
21. Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener R. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer 12(1), 35 (2012).
22. Na YR, Seok SH, Kim DJ et al. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci. 100(11), 2218-2225 (2009).
23. Kobayashi A, Okuda H, Xing F et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med. 208(13), 2641-2655 (2011).
24. Sakai H, Furihata M, Matsuda C et al. Augmented autocrine bone morphogenic protein (BMP) 7 signaling increases the metastatic potential of mouse breast cancer cells. Clin. Exp. Metastasis 29(4), 327-338 (2012).